B Lymphoblastic Leukemia Lymphoma With Recurrent Genetic Abnormality C2698313
A fast-growing blood cancer where abnormal B-cells multiply in bone marrow and blood. It most often affects children but can occur at any age. Treatment involves chemotherapy and may include targeted drugs based on the specific genetic change.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Easy bruising
Bone pain
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Hepatosplenomegaly
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Risk-Adapted Chemotherapy
Multi-phase chemotherapy tailored to specific genetic abnormalities identified, with risk stratification guiding treatment intensity from standard consolidation to augmented intensification protocols.
Targeted Biologic Therapy
Precision medicine approach using targeted agents such as tyrosine kinase inhibitors, BCL-2 inhibitors, or antibody-drug conjugates based on identified genetic abnormalities.
Additional treatment options
Allogeneic Stem Cell Transplant
Curative-intent transplantation using healthy donor cells following myeloablative conditioning, indicated for high-risk genetic abnormalities or suboptimal response to primary therapy.
procedureSerial Genetic Monitoring
Continuous molecular monitoring for disease burden and genetic evolution throughout treatment course, enabling early intervention for emerging resistance mechanisms.
monitoringNeutropenic Dietary Management
Specialized dietary approach during neutropenic periods including food safety precautions, avoidance of raw foods, and emphasis on well-cooked nutrient-dense options to prevent infections.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is B Lymphoblastic Leukemia Lymphoma With Recurrent Genetic Abnormality C2698313?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Alvarnas JC, Brown PA, Aoun PA, et al. NCCN Guidelines Version 2.2022 Acute Lymphoblastic Leukemia. J Natl Compr Canc Netw. 2022.
Roberts KG, Mullighan CG. The biology of B-progenitor acute lymphoblastic leukemia. Cold Spring Harb Perspect Med. 2020.
Slayton WB, Kairalla JA, Dover EK, et al. Dasatinib Plus Multiagent Chemotherapy in Philadelphia Chromosome-Positive ALL. J Clin Oncol. 2022.
Wang Y, Zhou W, Yang C, Liu J. Prognostic significance of genetic abnormalities in B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis. Cancer. 2021.
Medication Comparisons
Compare medications used to treat B Lymphoblastic Leukemia Lymphoma With Recurrent Genetic Abnormality C2698313. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy